Ependymoma medical therapy

Jump to navigation Jump to search

Ependymoma Microchapters


Patient Information


Historical Perspective




Epidemiology and Demographics

Risk Factors

Differentiating Ependymoma from other Diseases

Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


Laboratory Findings




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ependymoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Ependymoma medical therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ependymoma medical therapy

CDC on Ependymoma medical therapy

Ependymoma medical therapy in the news

Blogs on Ependymoma medical therapy

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Ependymoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]


The predominant therapy for ependymoma is surgical resection. Adjunctive chemoradiation may be required.


  • There is no evidence to date that adjuvant chemotherapy, including the use of myeloablative chemotherapy, improves the outcome for patients with totally resected, nondisseminated ependymoma.[1]
  • Current treatment approaches do not include chemotherapy as a standard component of primary therapy for children with newly diagnosed ependymomas that are completely resected.
  • Etoposide may be used in recurrent cases.

Radiation Therapy

  • Radiation therapy consisting of 54 gray to 55.8 gray is recommended for children aged 3 years and older who are diagnosed with well-differentiated ependymomas.[2]
  • It is not necessary to treat the entire CNS (whole brain and spine) because these tumors usually recur initially at the local site.
  • When possible, patients should be treated in a center experienced with the delivery of highly conformal radiation therapy (including intensity-modulated radiation therapy or charged-particle radiation therapy) to pediatric patients with brain tumors.


  1. Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC; et al. (2007). "Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue". Pediatr Blood Cancer. 49 (1): 34–40. doi:10.1002/pbc.20935. PMID 16874765.
  2. Ependymoma treatment. http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq#section/_48 URL Accessed on 10/13/2015.

Template:WikiDoc Sources